【レポートの概要（一部）】
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 6
1.2 List of Figures 9
2 Pharmaceuticals & Healthcare, Global, Deal Summary 12
2.1 Pharmaceuticals & Healthcare, Global, Deal Analysis, November 2013 12
2.2 Pharmaceuticals & Healthcare, Global, Major Deals, November 2013 14
2.2.1 Shire to Acquire ViroPharma for US$4.2 Billion 14
2.2.2 Salix Pharma Commences Cash Tender Offer to Acquire Santarus for US$2.6 Billion 15
2.2.3 Perrigo Completes Private Placement of Notes for US$2.3 Billion 16
2.2.4 CVS Caremark to Acquire Coram from Apria Healthcare for US$2.1 Billion 16
2.2.5 Mylan Completes Public Offering of Notes for US$2 Billion 17
2.3 Pharmaceuticals & Healthcare, Global, by Type, Number of Deals, November 2013 18
2.4 Pharmaceuticals & Healthcare, Global, by Type, Deal Values, November 2013 19
3 Pharmaceuticals and Healthcare, Global, Deals, Summary, by Type 20
3.1 Pharmaceuticals & Healthcare, Global, M&A, November 2013 20
3.1.1 Top M&A Deals in November 2013 22
3.1.2 Pharmaceuticals & Healthcare, Global, M&A Deals by Therapy Area, June 2013 – November 2013 23
3.2 Pharmaceuticals & Healthcare, Global, Equity Offering Deals, November 2013 25
3.2.1 Top Equity Offering Deals in November 2013 27
3.2.2 Pharmaceuticals & Healthcare, Global, Equity Offering Deals by Therapy Area, June 2013 – November 2013 28
3.3 Pharmaceuticals & Healthcare, Global, Private Equity and Venture Capital Deals, November 2013 30
3.3.1 Top PE/VC Deals in November 2013 31
3.3.2 Pharmaceuticals & Healthcare, Global, PE/VC by Therapy Area, November 2013 32
3.3.3 Pharmaceuticals & Healthcare, Global, Venture Capital Deals by Stage of Financing, November 2013 34
3.3.4 Pharmaceuticals & Healthcare, Global, Top Venture Financing Firms, June 2013-November 2013 36
3.3.5 Pharmaceuticals & Healthcare, Global, Top VC Backed Companies, June 2013-November 2013 38
4 Pharmaceuticals & Healthcare, Global, Partnership Deals, November 2013 39
4.1 Pharmaceuticals & Healthcare, Global, Partnership Deals, November 2013 39
4.2 Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, June 2013 – November 2013 41
4.3 Pharmaceuticals & Healthcare, Global, Partnership Deals by Upfront and Milestone Payments and Deal Values (US$ m), November 2013 43
4.3.1 Pharmaceuticals & Healthcare, Global, Top Partnership Deals by Payment Mode, November 2013 44
4.4 Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, by Upfront and Milestone Payments and Deal Values (US$ m), June 2013 – November 2013 45
4.5 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, Number Of Deals, June 2013 – November 2013 47
4.6 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, Deal Values (US$ m), June 2013 – November 2013 48
4.7 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, by Upfront & Milestone Payments and Deal Values (US$ m), June 2013 – November 2013 50
5 Pharmaceuticals & Healthcare, Global, Licensing Agreements, November 2013 52
5.1 Pharmaceuticals & Healthcare, Global, Licensing Agreements, November 2013 52
5.2 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, Upfront and Milestone Payments and Deal Values (US$ m), November 2013 54
5.2.1 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements by Deal Value, November 2013 56
5.2.2 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements, by Total Upfront Payments, November 2013 57
5.2.3 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements by Total Milestone Payment, November 2013 57
5.3 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Total Deal Values (US$ m), June 2013 – November 2013 58
5.4 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Upfront Payments and Milestone Payments (US$ m), June 2013 – November 2013 60
5.5 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, Total Deal Values (US$ m), June 2013 – November 2013 62
5.6 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, Upfront Payments and Milestone Payments (US$ m), June 2013 – November 2013 64
6 Pharmaceuticals & Healthcare, Global, Deal Summary by Therapy Area 66
6.1 Pharmaceuticals & Healthcare, Global, Oncology Deals, November 2013 66
6.1.1 Oncology – Deals of the Month 68
6.2 Pharmaceuticals & Healthcare, Global, Central Nervous System Deals, November 2013 70
6.2.1 Central Nervous System – Deals of the Month 72
6.3 Pharmaceuticals & Healthcare, Global, Immunology Deals, November 2013 74
6.3.1 Immunology – Dealsof the Month 76
6.4 Pharmaceuticals & Healthcare, Global, Cardiovascular Deals, November 2013 77
6.4.1 Cardiovascular – Deal of the Month 79
6.5 Pharmaceuticals & Healthcare, Global, Infectious Disease Deals, November 2013 81
6.5.1 Infectious Diseases – Deals of the Month 83
6.6 Pharmaceuticals & Healthcare, Global, Metabolic Disorder Deals, November 2013 84
6.6.1 Metabolic Disorders – Deal of the Month 86
6.7 Pharmaceuticals & Healthcare, Global, Gastrointestinal, Deals, November 2013 88
6.7.1 Gastrointestinal – Deal of the Month 90
7 Deal Summary by Geography 91
7.1 Pharmaceuticals & Healthcare, North America Deals, November 2013 91
7.1.1 North America – Deals of the Month 93
7.2 Pharmaceuticals & Healthcare, Europe, Deals, November 2013 95
7.2.1 Europe – Deals of the Month 96
7.3 Pharmaceuticals & Healthcare, Asia-Pacific, Regional Deals, November 2013 98
7.3.1 Asia-Pacific – Deals of the Month 100
7.4 Pharmaceuticals & Healthcare, Rest of the World, Deals, November 2013 101
7.4.1 Rest of the World – Deals of the Month 102
8 Pharmaceuticals & Healthcare, Global, Top Financial Advisors 103
8.1 Pharmaceuticals & Healthcare, Global, Top Financial Advisors, M&A, June 2013 – November 2013 103
8.2 Pharmaceuticals & Healthcare, Global, Top Financial Advisors, Equity Offerings, June 2013 – November 2013 105
9 Further Information 107
9.1 Methodology 107
9.2 About GlobalData 108
9.3 Disclosure information 109
9.4 Disclaimer 109
【レポート販売概要】
■ タイトル：事業提携・ライセンシング・投資・M&A動向：November 2013（製薬業界）■ 英文：Partnerships, Licensing, Investments and M&A Deals and Trends for November 2013 in Pharmaceuticals
■ 発行日：2013年12月15日
■ 調査会社：GlobalData
■ 商品コード：GDATA403163262
■ 調査対象地域：グローバル
- 世界の鎮痛剤注入ポンプ市場2015The Global Analgesic Infusion Pumps Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Analgesic Infusion Pumps industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Analgesic Infusion Pumps market analysis is provided for the international markets inclu …
- 低カロリー甘味料の世界市場：ステビア、キシリトール、アスパルテーム、スクラロース、チクロ、サッカリン、アセスルファムＫThe global low-calorie sweeteners market will see significant growth in the next ten years, doubling in its size by 2025. Visiongain estimates that in 2015 the market will be worth $11.4bn. The major drivers of the low-calorie sweeteners market include the growing demand for diet food, increasing levels of obesity, diabetes and other metabolic disorders. Moreover, in a market environment where sug …
- レーダ装置の世界市場：CWレーダ、パルスレーダThe radar systems market is expected to grow from USD 20.29 Billion in 2016 to USD 26.37 Billion by 2021, at a CAGR of 5.39% .from 2016 to 2021. The increased usage of radar systems in unmanned vehicles and homeland security is expected to drive the growth of the radar systems market in the coming years. Based on technology, the radar systems market has been segmented into pulsed radar and continu …
- アルミニウム製熱シールドの世界市場Aluminum heat shield market projected to reach USD 1.02 billion by 2021The global aluminum heat shield market is projected to reach USD 1.02 billion by 2021, at a CAGR of 4.5% from 2016 to 2021. Increasing vehicle production across the globe is one of the factors driving the growth of the aluminum heat shield market. Rising concern towards safety in automotive and firearms is another factor that h …
- 医療用食品の世界市場分析：製品タイプ別、用途タイプ別（糖尿病性ニューロパチー、[ADHD]、うつ病、アルツハイマー病、栄養欠乏）、セグメント予測、2014 – 2025The global medical foods market is expected to reach a value of USD 24.4 billion by 2025, according to a new report by Grand View Research, Inc. The medical foods market is anticipated to grow at a CAGR of 6.9% over the forecast period. The key factors supporting expansion include the growing awareness about medical foods, improvement in patient healthcare outcomes, rise in prevalence of several c …
- フレークアイス製氷機の世界市場2015-2019About ice flakers Flake ice can be either scale or granular ice. Most flake machines use a stationary evaporator. Flake ice is constantly scraped from the evaporator walls of the ice making machine by a slowly rotating auger. Ice flakers are highly moldable, have a large surface area, and no hard edges. They are used for a variety of cooling purposes across healthcare, industrial, and commercial a …
- 世界の軍事航空MRO（保守、修理、点検）市場（2014-2024）Summary The Global Military Aviation MRO Market 2014-2024 Report published by Strategic Defence Intelligence, provides readers with a detailed analysis of both historic and forecast global industry values, factors influencing demand, the challenges faced by industry participants, analysis of industry leading companies, and key news. Key Findings - The global military aviation MRO market is expecte …
- Unit Corporation：石油・ガスの開発・生産動向及びコスト分析- Q2, 2013Unit Corporation Oil & Gas Exploration and Production Operations and Cost Analysis - Q2, 2013 Summary Unit Corporation Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source for key o …
- 世界の電気外科デバイス市場2015The Global Electrosurgical Devices Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Electrosurgical Devices industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Electrosurgical Devices market analysis is provided for the international markets includin …
- 防火ガラスの世界市場分析：製品別（ワイヤー入り、セラミック、強化、ゲル充填）、用途別（建設、海洋）、セグメント予測The global fire resistant glass market is expected to reach USD 7.28 billion by 2024, according to a new report by Grand View Research, Inc. Rising demand for fire resistant glass owing to the increasing investments by the regional governments on infrastructure development in emerging regions including Asia Pacific and the Middle East is expected to drive the market over the next eight years. Risi …
- 賦形剤の世界市場：有機賦形剤、無機賦形剤About Excipients Excipients are pharmacologically inactive substances used in the form of a carrier with the active ingredient of a medication. Excipients help stabilize the active ingredient of a drug for a longer period and are used as a bulking up agent in drug formulations. Excipients are classified primarily based on their product type, functionality, and category. The Global Excipients marke …
- Polyoxin Bの世界市場POLYOXIN B (CAS 19396-06-6) Market Research Report 2012 presents comprehensive data on polyoxin b markets globally and regionally (Europe, Asia, North America etc.) The report includes polyoxin b description, covers its application areas and related patterns. It overviews polyoxin b market, names polyoxin b producers and indicates its suppliers. Besides, the report provides polyoxin b prices in re …
- スチレンブタジエンゴム（SBR）の世界市場分析：製品別（E-SBR、S-SBR）、用途別（タイヤ、履物、ポリマー改質、接着剤）、地域別（北アメリカ、ヨーロッパ、アジア太平洋）、セグメント予測、2014-2025The global styrene butadiene rubber (SBR) market is expected to reach USD 9.9 billion by 2025, according to a new report by Grand View Research, Inc. Significant increase in the demand for OEM tires from the automobile industry is likely to augment the utilization of SBR over the forecast period. In addition, long vehicle life coupled with a shift in consumer preference toward high-performance tir …
- がん医療におけるゲノミクスの世界市場分析：製品別（機器、消耗品、サービス）、用途別（診断、個別化医療、薬の発見･開発、研究）、技術別（ゲノム配列決定、PCR、マイクロアレイ、核酸抽出および精製）、エンドユーザー別（病院、研究機関、学術機関）、セグメント予測Global genomics in cancer care market is expected to reach USD 9.22 billion by 2022, according to a new report by Grand View Research, Inc. Increasing prevalence of cancer coupled with adoption of next generation sequencing for the diagnosis & treatment is expected to fuel the market with future growth opportunities. Increasing incidences of cancer triggers the demand for cost effective and accura …
- 自動車用地図の世界市場2018-2022About Automotive Maps Digital mapping is a process of compiling collected data to produce maps in the form of virtual images, which accurately represent a geographical area, major roads, rivers, and important landmarks such as airports, tourist attractions, and hospitals in and around the region. Technavio’s analysts forecast the global automotive maps market to grow at a CAGR of 9.56% during the …
